Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

Ryan Paige has called Biddeford home his entire life. He grew up in the city, attended its schools and spent time with ...

Nearly 50 million people in the United States struggle with substance use disorders, and nearly three in four use more than one substance. People with polysubstance use disorders are more likely than ...

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be ...

From online forums to the clinic, people have reported that diabetes and weight-loss drugs such as Ozempic and Wegovy can ...

In 524,817 adults with T2D, GLP-1 RA use was associated with lower incident alcohol, cocaine, cannabis, opioid, and nicotine ...

Between four and 10 million people in the U.S. have fibromyalgia. Many doctors look askance at the disorder, leading some ...

Increasingly popular GLP-1 drugs used to treat diabetes and obesity show promise in fighting multiple substance use disorders ...

Substance use disorder makes it hard to stop using substances even when they're harmful. Using the term "substance use disorder" helps separate the person from the treatable illness. Substance use ...

People struggling with many addictions, ranging from opioids to gambling, are reporting similar experiences in clinics, on ...

Dentistry has long been built on preventive care. It’s time to extend that preventive mindset to substance use.

Polysubstance use disorder is a mental health condition in which someone uses more than one substance at the same time or within a short period of time, despite a pattern of negative effects.